Sequence information
Variant position: 211 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: 411 The length of the canonical sequence.
Location on the sequence:
QDRASSDLPSPLEKADSESN
K GKKRRNRTTFTSYQLEELEK
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human QDRASSDLPSPLEKADSESNK GKKRRNRTTFTSYQLEELEK
Mouse QDRASAEIPSPLEKTDSESNK GKKRRNRTTFTSYQLEELEK
Bovine QDRASADLPSPMEKADSESNK GKKRRNRTTFTSYQLEELEK
Sequence annotation in neighborhood: The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Type Positions Description
Chain
1 – 411
Homeobox protein aristaless-like 4
Modified residue
200 – 200
Phosphoserine
Literature citations
ALX4 gain-of-function mutations in nonsyndromic craniosynostosis.
Yagnik G.; Ghuman A.; Kim S.; Stevens C.G.; Kimonis V.; Stoler J.; Sanchez-Lara P.A.; Bernstein J.A.; Naydenov C.; Drissi H.; Cunningham M.L.; Kim J.; Boyadjiev S.A.;
Hum. Mutat. 33:1626-1629(2012)
Cited for: VARIANTS CRS5 PHE-7 AND GLU-211; VARIANT LEU-306; CHARACTERIZATION OF VARIANTS CRS5 PHE-7 AND GLU-211; CHARACTERIZATION OF VARIANT LEU-306;
Disclaimer:
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.